Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$225,132,721
+$38,917,597 QoQ
Shares Held
886,454
+16.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#188
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$132,672
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $1,312,781,180 across 10 Drug Manufacturers - General names. JNJ ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,191,725 | $281,636,662 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
886,454 | $225,132,721 | |
| 3 | LLY |
ELI LILLY & Co
|
173,376 | $207,952,392 | |
| 4 | NVO |
Novo Nordisk A S
|
3,065,015 | $146,936,818 | |
| 5 | PFE |
Pfizer Inc
|
4,423,296 | $106,512,967 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
791,956 | $100,055,721 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,726,026 | $99,453,618 | |
| 8 | ABBV |
AbbVie Inc.
|
337,881 | $85,024,374 |
All Filings in JNJ
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,132,721 | 886,454 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $186,215,124 | 761,803 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $247,419,900 | 1,195,554 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $301,405,957 | 1,625,531 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $118,937,718 | 778,643 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $100,195,718 | 604,171 | Shares | Defined | 2025-07-02 | |
| 2025-03-31 | $132,672 | 800 | Put | Defined | 2025-07-02 | |
| 2024-12-31 | $115,696 | 800 | Put | Defined | 2025-07-02 | |
| 2024-12-31 | $65,457,469 | 452,617 | Shares | Defined | 2025-07-02 | |
| 2024-09-30 | $99,542,437 | 614,232 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $99,112,994 | 678,113 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $94,043,321 | 594,496 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $91,243,211 | 582,131 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $38,968,182 | 250,197 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $147,539,396 | 891,369 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $162,963,590 | 1,051,378 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $49,085,910 | 277,871 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $18,281,779 | 111,911 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $135,222,146 | 761,772 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $202,817,225 | 1,144,373 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $233,368,048 | 1,364,167 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $224,500,180 | 1,390,094 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $181,597,019 | 1,102,325 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $141,158,570 | 858,890 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $287,051,046 | 1,823,936 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $233,770,034 | 1,570,191 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $95,855,937 | 681,618 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $246,432,214 | 1,879,297 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||